Lactoferrin--a multifunctional protein with antimicrobial properties.

Lactoferrin is a member of the transferrin family of iron-binding proteins. Numerous functions have been reported and continue to be reported for the protein, some of which are related to its iron-binding properties. Its extensive antimicrobial activities were originally attributed to its ability to sequester essential iron, however, it is now established that it possesses bactericidal activities as a result of a direct interaction between the protein or lactoferrin-derived peptides. This article reviews the antimicrobial activities of lactoferrin and discusses the potential mode of action of lactoferrin-derived cationic peptides against Gram-negative bacteria in the light of recent studies.

[1]  I. Green,et al.  Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. , 1971, The Journal of infectious diseases.

[2]  D. Colavizza,et al.  Molecular cloning and sequence analysis of bovine lactotransferrin. , 1991, European journal of biochemistry.

[3]  S. Teraguchi,et al.  Inhibition of Hyphal Growth of Azole-Resistant Strains of Candida albicans by Triazole Antifungal Agents in the Presence of Lactoferrin-Related Compounds , 1998, Antimicrobial Agents and Chemotherapy.

[4]  A. Hovanessian,et al.  Gel isoelectric focusing of human-serum transferrin. , 1976, European journal of biochemistry.

[5]  D. Mann,et al.  Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. , 1994, The Journal of biological chemistry.

[6]  Miguel Calvo Rebollar,et al.  Biological role of lactoferrin. , 1992, Archives of disease in childhood.

[7]  R. Arnold,et al.  Bactericidal activity of human lactoferrin: influence of physical conditions and metabolic state of the target microorganism , 1981, Infection and immunity.

[8]  K. Yamauchi,et al.  Identification of the bactericidal domain of lactoferrin. , 1992, Biochimica et biophysica acta.

[9]  J. Esposito,et al.  Enterovirus type 70 virion and intracellular proteins , 1976, Journal of virology.

[10]  H. Nikaido,et al.  Outer membrane of Salmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants , 1975, Journal of bacteriology.

[11]  C. Edmiston,et al.  IRON AND INFECTION: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, 2ND EDITION , 1999 .

[12]  R. Hancock,et al.  Cationic peptides: a new source of antibiotics. , 1998, Trends in biotechnology.

[13]  R. Houghten,et al.  The antimicrobial activity of hexapeptides derived from synthetic combinatorial libraries. , 1995, The Journal of applied bacteriology.

[14]  M. Tomita,et al.  Potent bactericidal activity of bovine lactoferrin hydrolysate produced by heat treatment at acidic pH. , 1991, Journal of dairy science.

[15]  D. Rice,et al.  Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 A resolution. , 1989, Journal of molecular biology.

[16]  A. Newsome,et al.  Characterization of Lactoferrin Interaction with Streptococcus mutans , 1987, Journal of dental research.

[17]  Edward N Baker,et al.  Lactoferrin and transferrin: functional variations on a common structural framework. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[18]  S. Kaneko,et al.  Hepatitis C virus envelope proteins bind lactoferrin , 1997, Journal of virology.

[19]  J. Tachezy,et al.  Tritrichomonas foetus: iron acquisition from lactoferrin and transferrin. , 1996, Experimental parasitology.

[20]  H. Vogel,et al.  The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles , 1999, FEBS letters.

[21]  R. Miller,et al.  Bactericidal effect of lactoferrin on Legionella pneumophila: effect of the physiological state of the organism. , 1989, Canadian journal of microbiology.

[22]  M. Groves.  The isolation of a red protein from milk. , 1960 .

[23]  R. Arnold,et al.  Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms , 1980, Infection and immunity.

[24]  K. Yamauchi,et al.  Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoites by treatment with bovine lactoferricin. , 2001, The Journal of veterinary medical science.

[25]  R. W. Evans,et al.  Antibacterial activity of peptides homologous to a loop region in human lactoferrin , 1996, FEBS letters.

[26]  M. Tomita,et al.  Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. , 1992, The Journal of applied bacteriology.

[27]  B. Appelmelk,et al.  Lactoferrin is a lipid A-binding protein , 1994, Infection and immunity.

[28]  L. Duret,et al.  Identification and molecular analysis of BANP. , 2000, Gene.

[29]  G. Ames,et al.  Protein Composition of the Outer Membrane of Salmonella typhimurium: Effect of Lipopolysaccharide Mutations , 1974, Journal of bacteriology.

[30]  J. Williams.  The evolution of transferrin , 1982 .

[31]  B. Dunn,et al.  Lactoferrin and transferrin damage of the gram-negative outer membrane is modulated by Ca2+ and Mg2+. , 1990, Journal of general microbiology.

[32]  H. Nikaido,et al.  Molecular basis of bacterial outer membrane permeability. , 1985, Microbiological reviews.

[33]  Y. Shai,et al.  Mode of action of the antibacterial cecropin B2: a spectrofluorometric study. , 1994, Biochemistry.

[34]  G. C. Gonzalez,et al.  Identification and characterization of a porcine‐specific transferrin receptor in Actinobacillus pleuropneumoniae , 1990, Molecular microbiology.

[35]  R. Houghten,et al.  Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery , 1991, Nature.

[36]  R. Arnold,et al.  Killing of Actinobacillus actinomycetemcomitans by human lactoferrin , 1988, Infection and immunity.

[37]  D. Meijer,et al.  Synergistic Fungistatic Effects of Lactoferrin in Combination with Antifungal Drugs against ClinicalCandida Isolates , 1999, Antimicrobial Agents and Chemotherapy.

[38]  R. Miller,et al.  Bactericidal effect of lactoferrin on Legionella pneumophila , 1986, Infection and immunity.

[39]  F. Barchiesi,et al.  Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline. , 2000, The Journal of antimicrobial chemotherapy.

[40]  P. Masson,et al.  Comparison of human lactoferrins from milk and neutrophilic leucocytes. Relative molecular mass, isoelectric point, iron-binding properties and uptake by the liver. , 1985, The Biochemical journal.

[41]  J. Brock.  The physiology of lactoferrin. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[42]  T. Yoneya,et al.  Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity. , 1989, Journal of biochemistry.

[43]  E. Benz,et al.  Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis. , 1987, Blood.

[44]  G. Barnickel,et al.  High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane , 1985, Journal of bacteriology.

[45]  R. Manservigi,et al.  Heparan Sulfate Proteoglycan Binding by Herpes Simplex Virus Type 1 Glycoproteins B and C, Which Differ in Their Contributions to Virus Attachment, Penetration, and Cell-to-Cell Spread , 1998, Journal of Virology.

[46]  R. Ellison,et al.  Killing of gram-negative bacteria by lactoferrin and lysozyme. , 1991, The Journal of clinical investigation.

[47]  M. Tomita,et al.  A review: The active peptide of lactoferrin , 1994, Acta paediatrica Japonica : Overseas edition.

[48]  V. Salmon,et al.  Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. , 1995, The Biochemical journal.

[49]  D. Herrington,et al.  Haemophilus influenzae can use human transferrin as a sole source for required iron , 1985, Infection and immunity.

[50]  C. Bevins.  Antimicrobial peptides as agents of mucosal immunity. , 1994, Ciba Foundation symposium.

[51]  K. Hahm,et al.  Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. , 2009, International journal of peptide and protein research.

[52]  N. Kato,et al.  Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. , 1998, Biochemical and biophysical research communications.

[53]  M. Tomita,et al.  Role of cell-binding in the antibacterial mechanism of lactoferricin B. , 1993, The Journal of applied bacteriology.

[54]  M. Rey,et al.  Complete nucleotide sequence of human mammary gland lactoferrin. , 1990, Nucleic acids research.

[55]  J. Tommassen,et al.  Molecular characterization of LbpB, the second lactoferrin‐binding protein of Neisseria meningitidis , 1998, Molecular microbiology.

[56]  A. S. Naidu,et al.  Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium , 1993, Antimicrobial Agents and Chemotherapy.

[57]  R. Hancock,et al.  Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa , 1981, Antimicrobial Agents and Chemotherapy.

[58]  A. Virtanen,et al.  Isolation of an iron-containing red protein from human milk. , 1960 .

[59]  F. Schoentgen,et al.  Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. , 1984, European journal of biochemistry.

[60]  J. Mcghee,et al.  A bactericidal effect for human lactoferrin. , 1977, Science.

[61]  H. Nojima,et al.  Molecular cloning and sequence analysis of human Na, K-ATPase β–subunit , 1986 .

[62]  Vanya Gant,et al.  Structure-Function Relationship of Antibacterial Synthetic Peptides Homologous to a Helical Surface Region on Human Lactoferrin against Escherichia coli Serotype O111 , 1998, Infection and Immunity.

[63]  S. Abe,et al.  Cooperative Anti‐Candida Effects of Lactoferrin or Its Peptides in Combination with Azole Antifungal Agents , 1996, Microbiology and immunology.

[64]  Anthony Maxwell,et al.  Mode of Action , 1998 .

[65]  K. Yamauchi,et al.  Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment , 1993, Infection and immunity.

[66]  B. Roe,et al.  Identification and Molecular Analysis oflbpBA, Which Encodes the Two-Component Meningococcal Lactoferrin Receptor , 1998, Infection and Immunity.

[67]  M. Viljoen,et al.  Lactoferrin: a general review. , 1995, Haematologica.

[68]  H. Vogel,et al.  Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. , 1998, Biochemistry.

[69]  Y. Shai,et al.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. , 1999, Biochimica et biophysica acta.

[70]  R. Hancock,et al.  The role of cationic antimicrobial peptides in innate host defences. , 2000, Trends in microbiology.

[71]  R. W. Evans,et al.  X-ray solution scattering reveals conformational changes upon iron uptake in lactoferrin, serum and ovo-transferrins. , 1992, Journal of Molecular Biology.

[72]  H. Nikaido,et al.  The Outer Membrane of Gram-negative Bacteria , 1980 .

[73]  H. Mihara,et al.  Engineering peptides and proteins that undergo α-to-β transitions , 1997 .

[74]  R. Arnold,et al.  Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility in vitro. , 1994, Diagnostic microbiology and infectious disease.

[75]  H. Baker,et al.  Structure of human lactoferrin at 3.2-A resolution. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[76]  K. Hoek,et al.  Antibacterial activity in bovine lactoferrin-derived peptides , 1997, Antimicrobial agents and chemotherapy.

[77]  R. Ellison,et al.  Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin , 1988, Infection and immunity.

[78]  H. G. Boman,et al.  Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.

[79]  T. Ganz,et al.  Defensins and other endogenous peptide antibiotics of vertebrates , 1995, Journal of leukocyte biology.

[80]  P. Masson,et al.  Lactoferrin in milk from different species. , 1971, Comparative biochemistry and physiology. B, Comparative biochemistry.

[81]  Stephen H. White,et al.  Experimentally determined hydrophobicity scale for proteins at membrane interfaces , 1996, Nature Structural Biology.